NAYA Biosciences, Inc (NAYA) — Cash Flow-to-Debt Ratio
NAYA Biosciences, Inc (NAYA) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2024, meaning its operating cash flow of $-617.38K could theoretically repay 0% of its total liabilities ($33.70 Million) in one year. See NAYA Biosciences, Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NAYA Biosciences, Inc Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for NAYA Biosciences, Inc across 14 annual periods. Also explore NAYA net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for NAYA Biosciences, Inc (2007–2024)
Year-by-year debt coverage analysis for NAYA Biosciences, Inc. For market capitalisation and broader financial context, see how much is NAYA Biosciences, Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.09x | $-2.97 Million | $33.70 Million | ▲ +67.3% |
| 2023 | -0.27x | $-4.76 Million | $17.61 Million | ▲ +80.8% |
| 2022 | -1.41x | $-6.60 Million | $4.69 Million | ▲ +26.3% |
| 2021 | -1.91x | $-6.03 Million | $3.16 Million | ▼ -108.3% |
| 2020 | -0.92x | $-4.78 Million | $5.20 Million | ▼ -468.8% |
| 2019 | 0.25x | $1.37 Million | $5.51 Million | ▲ +233.4% |
| 2018 | -0.19x | $-652.97K | $3.50 Million | ▼ -441.0% |
| 2017 | -0.03x | $-181.27K | $5.26 Million | ▲ +47.8% |
| 2016 | -0.07x | $-323.90K | $4.90 Million | ▼ -88.9% |
| 2015 | -0.03x | $-151.62K | $4.34 Million | ▲ +70.5% |
| 2010 | -0.12x | $-315.99K | $2.66 Million | ▲ +54.9% |
| 2009 | -0.26x | $-926.66K | $3.52 Million | ▲ +75.6% |
| 2008 | -1.08x | $-1.07 Million | $988.12K | ▼ -45.8% |
| 2007 | -0.74x | $-116.04K | $156.70K | — |